Entacapone Market Sluggish Growth Rate Foreseen by 2023-2029
Entacapone market is anticipated to grow at a significant CAGR during the forecast period. Entacapone is used by combining with levodopa/carbidopa for the treatment of the end-of-dose "wearing-off" effect in patients with Parkinson's disease. Parkinson's disease is a disorder of the central nervous. It is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. The major factor for the growth of the market is the increasing prevalence of Parkinson disease.
According to the Parkinson
Foundation, almost one million people are living with Parkinson disease in the
US which is expected to rise to 1.2 million in 2030. Additionally,
approximately 60,000 Americans are diagnosed with PD each year and more than 10
million people are living with PD globally. Further, PD disease increases with
age however, an estimated 4% of people with PD are diagnosed before age 50.
Moreover, the prevalence of PD in men are 1.5 times as compared to women.
However, increasing cost for the treatment of PD is hampering the growth of the
global entacapone market during the forecast period.
Some major key players in the
market include Novartis International AG, Teva Pharmaceutical Industries Ltd.,
and Sun Pharmaceutical Industries Ltd., among others. The market players are
contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical
expansion, partnerships and collaborations, and new product launches, to stay
competitive in the market. For instance, in February 2021, STADA declared
European launch of the Lecigon triple-combination of levodopa, carbidopa, and
entacapone for treating advanced Parkinson's disease.
To Request
a Sample of our Report on Entacapone Market: https://www.omrglobal.com/request-sample/entacapone-market
Market Coverage
• The
market number available for – 2021-2029
• Base
year- 2021
• Forecast
period- 2023-2029
Segment Covered-
·
By Product
·
By Application
Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-Novartis
International AG, Teva Pharmaceutical Industries Ltd.,and Sun Pharmaceutical
Industries Ltd., among others.
Entacapone Market Report by
Segment
By Product
•
Purity:98%
•
Purity: above 98%
By Application
•
Tablet Product
•
Capsule Product
•
Others
A full Report of Entacapone Market is Available @ https://www.omrglobal.com/industry-reports/entacapone-market
Entacapone Market Report by
Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries,
further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for
investigation.
4. Our expert research analysts answer all your
questions before and after purchasing your report.
For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/entacapone-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Comments
Post a Comment